|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| G01N2333/723 | (2013.01) | ||
| G01N 33/57434 | (2013.01) |
| (11) | Number of the document | 3353553 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16849728.7 |
| Date of filing the European patent application | 2016-09-23 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/053387 |
| Date | 2016-09-23 |
| (87) | Number | WO 2017/053763 |
| Date | 2017-03-30 |
| (30) | Number | Date | Country code |
| 201562233206 P | 2015-09-25 | US |
| (72) |
DITTAMORE, Ryan , US
|
| (73) |
Epic Sciences, Inc. ,
9381 Judicial Drive, Suite 200, San Diego, CA 92121,
US
|
| (54) | ANDROGEN RECEPTOR VARIANT 7 AS A BIOMARKER FOR TREATMENT SELECTION IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) |
| ANDROGEN RECEPTOR VARIANT 7 AS A BIOMARKER FOR TREATMENT SELECTION IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) |